MétaCan
Menu
Back to cohort
Record W4402766756 · doi:10.1016/j.eclinm.2024.102838

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

2024· review· en· W4402766756 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueEClinicalMedicine · 2024
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsHealth Canada
FundersJanssen PharmaceuticalsNational Institute for Health Research Applied Research Collaboration WestMSD K.K.GenentechChugai PharmaceuticalAgency for Healthcare Research and QualityCenters for Disease Control and PreventionNational Institutes of HealthShionogiAstellas PharmaEisaiCancer Research UKNational Eye InstituteSeagenNational Institute for Health and Care ResearchMedical Research CouncilVerily Life SciencesDepartment of Health and Social CareMacroGenicsImperial Experimental Cancer Medicine CentreAnthony NolanMassachusetts Medical SocietySarcoma UKNational Cancer InstituteGilead SciencesYale UniversityGlaxoSmithKlineUK Research and InnovationEli Lilly and CompanyBristol-Myers SquibbAstraZenecaAmgenBirmingham Biomedical Research CentrePfizerAstex PharmaceuticalsPfizer PharmaceuticalsAmerican Heart Association
KeywordsMedicineTolerabilityClinical trialPatient carePhase (matter)Medical physicsIntensive care medicineAlternative medicineNursingInternal medicinePathology

Abstract

fetched live from OpenAlex

Early phase clinical trials provide an initial evaluation of therapies' risks and benefits to patients, including safety and tolerability, which typically relies on reporting outcomes by investigator and laboratory assessments. Use of patient-reported outcomes (PROs) to inform risks (tolerability) and benefits (improvement in disease symptoms) is more common in later than early phase trials. We convened a two-day expert roundtable covering: (1) the necessity and feasibility of a universal PRO core conceptual model for early phase trials; (2) the practical integration of PROs in early phase trials to inform tolerability assessment, guide dose decisions, or as real-time safety alerts to enhance investigator-reported adverse events. Participants (n = 22) included: patient advocates, regulators, clinicians, statisticians, pharmaceutical representatives, and PRO methodologists working across diverse clinical areas. In this manuscript, we report major recommendations resulting from the roundtable discussions corresponding to each theme. Additionally, we highlight priority areas necessitating further investigation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.059
metaresearch head score (Gemma)0.113
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow), Meta-epidemiology (broad)
Consensus categoriesMetaresearch
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.956
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0590.113
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0160.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.634
GPT teacher head0.629
Teacher spread0.005 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it